Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for VCEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 -2.858M
March 31, 2026 -1.563M
December 31, 2025 -1.255M
September 30, 2025 -1.482M
June 30, 2025 -1.788M
March 31, 2025 -9.409M
December 31, 2024 -7.261M
September 30, 2024 -5.795M
June 30, 2024 -4.434M
March 31, 2024 -7.026M
December 31, 2023 -1.386M
September 30, 2023 -1.116M
June 30, 2023 -1.273M
March 31, 2023 -2.225M
December 31, 2022 -0.612M
September 30, 2022 -0.829M
June 30, 2022 -0.746M
March 31, 2022 -1.465M
December 31, 2021 -1.483M
September 30, 2021 -2.08M
June 30, 2021 -3.84M
March 31, 2021 -3.781M
December 31, 2020 -4.45M
September 30, 2020 -0.809M
June 30, 2020 -0.953M
Date Value
March 31, 2020 -0.42M
December 31, 2019 -1.524M
September 30, 2019 -1.703M
June 30, 2019 -1.061M
March 31, 2019 -0.998M
December 31, 2018 -1.051M
September 30, 2018 -1.903M
June 30, 2018 -71.44M
March 31, 2018 -2.712M
December 31, 2017 -4.888M
September 30, 2017 -7.417M
June 30, 2017 -0.061M
March 31, 2017 -0.071M
December 31, 2016 -18.99M
September 30, 2016 -0.117M
June 30, 2016 -0.094M
March 31, 2016 -0.258M
December 31, 2015 0.00
September 30, 2015 -0.008M
June 30, 2015 -0.003M
March 31, 2015 0.00
December 31, 2014 0.302M
September 30, 2014 -41.32M
June 30, 2014 -3.462M
March 31, 2014 -5.455M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 9.00M
ADMA Biologics, Inc. 25.02M
Kyntra Bio, Inc. 0.00
Conexeu Sciences, Inc. -2.427M
ACADIA Pharmaceuticals, Inc. -10.49M